by Dr. Agarwal’s Health Care Limited IPO: A Retail Investor’s Guide
Introduction
Dr. Agarwal’s Health Care Limited, a leading eye care hospital chain in India, is launching its Initial Public Offering (IPO) from January 29, 2025, to January 31, 2025. Retail investors looking for an opportunity in the healthcare sector should carefully analyze this IPO’s prospects. In this blog, we will cover the key details of the IPO and what retail investors should consider before investing.
About Dr. Agarwal’s Health Care Limited
Dr. Agarwal’s Health Care is a well-established name in the Indian healthcare sector, specializing in ophthalmology. The company operates numerous eye care hospitals across India and has expanded its services internationally. With its strong reputation and increasing demand for specialized eye care, the company aims to strengthen its financial position through this IPO.
IPO Details
- Symbol: AGARWALEYE
- Issue Period: January 29, 2025 – January 31, 2025
- Issue Size: Rs. 3,000 million (Fresh Issue) + 67,842,284 Equity Shares (Offer for Sale)
- Issue Type: 100% Book Building
- Price Band: Rs. 382 – Rs. 402 per share
- Face Value: Rs. 1 per Equity Share
- Bid Lot: 35 shares and multiples thereof
- Retail Investor Maximum Subscription: Rs. 2,00,000
- IPO Market Timings: 10:00 AM to 5:00 PM
- UPI Mandate Cut-off Time: January 31, 2025, 5:00 PM
- Registrar: KFin Technologies Limited
- Lead Managers: Kotak Mahindra, Morgan Stanley, Jefferies India, Motilal Oswal
Why Should Retail Investors Consider This IPO?
1. Strong Brand Presence
Dr. Agarwal’s Health Care has a well-established brand in the healthcare industry, known for its quality eye care services and advanced technology in ophthalmology.
2. Growing Healthcare Sector
With the increasing demand for specialized healthcare services in India, particularly in eye care, the company has strong growth potential.
3. Expansion Plans
The proceeds from the fresh issue will be used for business expansion, debt repayment, and general corporate purposes, strengthening the company’s financial position.
4. Competitive Pricing
The price band of Rs. 382 – Rs. 402 per share offers a reasonable valuation considering the company’s financial growth and market potential.
Risks to Consider
- Market Volatility: IPO investments are subject to market risks and fluctuations.
- Sector Competition: The healthcare sector is highly competitive, with both established players and new entrants.
- Regulatory Risks: Any changes in government regulations related to healthcare could impact business operations.
How to Apply for Dr. Agarwal’s Health Care IPO?
Example for Retail Investors:
Let’s say you want to invest in Dr. Agarwal’s IPO with a retail investor limit of Rs. 2,00,000. Here’s how you can proceed:
- Choose Your Platform: Use your preferred broker (Zerodha, Groww, Upstox, or bank-based ASBA services like ICICI, HDFC, SBI, etc.).
- Select IPO & Enter Details: Navigate to the IPO section, select Dr. Agarwal’s Health Care Limited IPO, and enter your bid price (within the price band Rs. 382 – Rs. 402) and quantity (multiples of 35 shares).
- Use UPI for Payment: Ensure you have a UPI ID linked to your bank. Enter your UPI ID, and approve the mandate request from your UPI app (Paytm, PhonePe, Google Pay, etc.).
- Wait for Allotment & Listing: The allotment status will be available on February 3, 2025. If allotted, shares will be credited to your demat account before the listing date on February 5, 2025.
FAQs
1. What is the minimum investment required?
The minimum investment is Rs. 13,370 (35 shares at Rs. 382) or Rs. 14,070 (35 shares at Rs. 402).
2. How will I know if I have received an allotment?
You can check the allotment status on the registrar’s website (KFin Technologies) or your broker’s platform on February 3, 2025.
3. What happens if I don’t get an allotment?
If you don’t receive an allotment, the blocked amount in your bank account will be automatically released.
4. What are the listing gains?
Listing gains depend on market demand, but the latest GMP suggests a possible 1.24% listing gain.
5. When will the IPO shares be listed on stock exchanges?
The shares are expected to be listed on the BSE and NSE on February 5, 2025.
LATEST GMP (as per Indiatoday Website)
The grey market premium (GMP) for Dr. Agarwal’s IPO has seen a decline in the unofficial market.
As of January 30, 2025, at 8:32 AM, the latest GMP was Rs. 5. Given the price band of Rs. 402, the estimated listing price is around Rs. 407, indicating a potential gain of approximately 1.24% per share.
The allotment of shares is expected to be finalized on Monday, February 3, 2025. The company’s shares are scheduled to be listed on the BSE and NSE, with the tentative listing date set for Wednesday, February 5, 2025.
“Discipline is the bridge between goals and accomplishment.” – Jim Rohn
